Best quality treatment for patient well being: a way to reduce social costs and alleviate personal suffering in dialysis
Artif Cells Blood Substit Immobil Biotechnol
.
2003 May;31(2):179-84.
doi: 10.1081/bio-120020176.
Authors
Mauro Atti
1
,
Fabio Grandi
Affiliation
1
Hospal S.p.A., Bologna, Italy. mauro.atti@hospal.com
PMID:
12751838
DOI:
10.1081/bio-120020176
No abstract available
Publication types
Review
MeSH terms
Benchmarking
Cost of Illness
Health Care Costs
Humans
Hypotension / etiology
Quality of Health Care* / economics
Quality of Life
Renal Dialysis / adverse effects
Renal Dialysis / economics
Renal Dialysis / standards*